跳至主要内容
临床试验/CTRI/2024/06/069171
CTRI/2024/06/069171尚未招募2/3 期

A Randomized Controlled Clinical Trial To Assess The Efficacy Of Kushmanda Kalyanaka In Karshya.

Dr Anagha Gulhane1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年6月29日最近更新:
适应症

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Patient will be checked for following symptoms:

研究概览

简要总结

This study is a randomized, single blind, parallel group, actively controlled clinical study with comparative standard drug - Ashwagandhadi Lehya  and interventional drug - Kushmanda Kalyanaka Avaleha with the dosage12 gms (Total: 24gms per day) empty stomach before to the meals as BID. This study is conducting on patients of Karshya belongs to age of 16yrs to 60yrs who gives written and verbal consent for undergoing clinical study. Study will be conducting in Alvas Ayurveda Medical College and Hospital, Vidyagiri, Moodbidri. Interventional period of this study is 60 days. Assessment will be done on 0th Day, 46th Day, 61st Day.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Participant Blinded

入排标准

年龄范围
16.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • •Patients between the age group of 16 to 60 years.
  • •Patient having at least one of the Nidana mentioned in Ayurvedic literature for Karshya will be included.
  • •Patient willing to sign Written Consent Form.

排除标准

  • •Patients with Karshyatha due to Tuberculosis, Malignancies and metabolic disorders.
  • •Patients with any other systemic disorders which will interfere the study will be excluded.

结局指标

主要结局

Patient will be checked for following symptoms:

时间窗: 60 Days

2) Intolerence to Physical work

时间窗: 60 Days

3) Intolerence to Hunger and Thrist

时间窗: 60 Days

4) Prominent Joints And Bones

时间窗: 60 Days

1) Prominent Vascular Network

时间窗: 60 Days

次要结局

  • The below Criteria will be Checked on 0Th day, 46th Day and 61st Day.(1) Weight)

研究者

发起方
Dr Anagha Gulhane
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验